Тёмный

Drug-Receptor Interactions: Affinity, Efficacy, CRCs & Antagonism 

EKG Science
Подписаться 8 тыс.
Просмотров 4,2 тыс.
50% 1

🧬 Subscribe for more science lectures:
ru-vid.com?...
In this lecture EKG is going to cover drug-receptor interactions.
We’ll explore important concepts like drug binding, affinity, efficacy, potency, and concentration response curves. We’ll also break down the role of agonist drugs and dive into the different types of antagonism.
Feeling a little under the dose of pharmacology? Subscribe to the channel and we'll fill your prescription with more pharma content! Seriously though be an agonist drug and bind to the subscribe button 😉
Lecture Overview:
0:00 Intro
0:22 Concept of Drug-Receptor Interaction
3:50 Affinity, Law of Mass Action & Equilibrium Dissociation Constant (KD)
11:55 Efficacy & Receptor States
16:50 Concentration-Response Curves (CRCs)
21:02 Emax & EC50
23:37 Potency
29:48 Subdivisions within Agonists: Full & Partial
31:22 Types of Antagonism - Competitive (Reversible & Surmountable) & Non-competitive (Irreversible & Insurmountable)
✏️ All diagrams were made by EKG.
For educational purposes only; NOT medical or other advice.
Lecture Source:
Ritter, J., Flower, R.J., Henderson, G., Yoon Kong Loke and Rang, H.P. (2018). Rang and Dale’s Pharmacology. 9th ed. Endinburgh: Elsevier.
---
💙 SUPPORT EKG SCIENCE
PayPal - www.paypal.com/paypalme/ekgsc...
📸 SOCIAL MEDIA
Instagram - / ekgscience
Twitter - / ekgscience
📚 STUDY NEXT:
Pharmacodynamics: GPCRs & Second Messengers - • G-Protein Coupled Rece...
Introduction To Pharmacokinetics - • Introduction to Pharma...
🌏 Our mission here at EKG Science is to serve the current and future generations of learners by creating free, world-class science lectures.
Write your story.
Remember, subtract complexity & slow down.
#pharmacodynamics #pharmacology #ekgscience

Наука

Опубликовано:

 

24 июл 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 15   
@TH-iq9ee
@TH-iq9ee 2 месяца назад
You are a gold and helped me so much!!!! Please keep doing these!!!
@EKGScience
@EKGScience 2 месяца назад
Appreciate you! Happy to hear it’s helped you 🙌🏽
@FRANCIS-b1d
@FRANCIS-b1d 21 день назад
you are FANTASTIC!!!!!♥. P;EASE DON'T STOP
@mulusimon3619
@mulusimon3619 4 месяца назад
amazing thankyou very much please dose response effects
@OluwafunmilayoO.-tt2mp
@OluwafunmilayoO.-tt2mp 7 месяцев назад
You're amazing. Thank you so much, I understand the concept much better- and yes you can have a bottle of water beside you, it helps with the talking (it's hard talking for long stretches without water) Thank you for simplifying the concept!
@EKGScience
@EKGScience 7 месяцев назад
Appreciate you! I’m glad it helped 🫶🏼
@FRANCIS-b1d
@FRANCIS-b1d 21 день назад
please cross check where you explained the two ways an insurmountable antagonism can be formed. i think you interchange "antagonist" for agonist. you said the higher the affinity of the agonist instead of the higher affinity of the antagonist. please i need a feedback i'm a student and you are fantastic + remarkable and then excellent.
@EKGScience
@EKGScience 21 день назад
Timestamp for when I said that so I can check?
@ntgb4295
@ntgb4295 3 месяца назад
Can I have this lecture as a PDF
@user-or6fp1gp8g
@user-or6fp1gp8g 6 месяцев назад
This is great ❤❤❤
@EKGScience
@EKGScience 6 месяцев назад
Appreciate you 💙
@Pharma635
@Pharma635 4 месяца назад
You are really amazing 💕🙏🏻
@EKGScience
@EKGScience 4 месяца назад
Appreciate you 💙
@MitikuMamo-hf4by
@MitikuMamo-hf4by 8 месяцев назад
It's better if possible obtain ppt of pharmacology
@EKGScience
@EKGScience 8 месяцев назад
Currently in the process of creating notes for it!
Далее
Introduction to Pharmacodynamics | Pharmacology
32:37
Я ВЕРНУЛСЯ 🔴 | WICSUR #shorts
00:57
Просмотров 767 тыс.
Autonomic Pharmacology | Adrenergic Antagonists
1:59:15
Просмотров 135 тыс.
Pharmacology - PHARMACODYNAMICS (MADE EASY)
12:51
Просмотров 986 тыс.
Drug Receptor interactions-Non Covalent Bonding
27:57
iPhone 15 Pro в реальной жизни
24:07
Просмотров 437 тыс.